Skip to main content
Retour
Watch Compare

Silo Pharma, Inc.

Qualité des données : 100%
SILO
Nasdaq Manufacturing Chemicals
0,44 €
▲ 0,03 € (6,04%)
Cap. Boursière: 6,77 M
Prix
0,42 €
Cap. Boursière
6,77 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -4,66 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)0,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-85,18%
En dessous de la moyenne du secteur (-53,47%)
ROIC-59,97%
Net Margin-5863,50%
Op. Margin-5936,95%

Sécurité

Debt / Equity
N/A
Current Ratio8,70
Interest Coverage-114,76

Valorisation

PE (TTM)
-1,60
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,35
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,6 -1,5
P/B 1,4 1,6
ROE % -85,2 -53,5
Net Margin % -5863,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 2 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42023 -0,20 € -0,36 € -80,0%
Q32023 -0,31 € -0,21 € +32,3%

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
1,47% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0,02% weight
AVES logo AVES Avantis Emerging Markets Value ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0,00% Revenue Growth (3Y) 0,00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72 102,0 Net Income (TTM) -4,23 M
ROE -85,18% ROA -64,86%
Gross Margin 38,57% Operating Margin -5936,95%
Net Margin -5863,50% Free Cash Flow (TTM) -4,66 M
ROIC -59,97% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8,70
Interest Coverage -114,76 Asset Turnover 0,01
Working Capital 5,46 M Tangible Book Value 4,79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,60 Forward P/E N/A
P/B Ratio 1,35 P/S Ratio 93,83
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -68,90%
Market Cap 6,77 M Enterprise Value 2,85 M
Per Share
EPS (Diluted TTM) -0,50 Revenue / Share 0,00
FCF / Share -0,29 OCF / Share -0,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 110,26%
SBC-Adj. FCF -4,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72 102,0 72 102,0 72 102,0 — —
Net Income -4,23 M -4,39 M -3,70 M -3,91 M 3,90 M
EPS (Diluted) -0,50 -1,19 — — 0,04
Gross Profit 27 807,0 66 264,0 66 264,0 66 264,0 66 260,0
Operating Income -4,28 M -4,71 M -3,86 M -3,63 M -2,74 M
EBITDA — — — — —
R&D Expenses 2,16 M 2,37 M 845 092,0 1,29 M 693 910,0
SG&A Expenses — — 390 071,0 227 259,0 162 953,0
D&A — — — — —
Interest Expense 37 302,0 5 084,0 4 869,0 2 199,0 54,0
Income Tax — — — 24 876,0 24 876,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7,61 M 7,41 M 7,75 M 11,64 M 10,49 M
Total Liabilities 1,30 M 2,38 M 1,57 M 1,30 M 1,43 M
Shareholders' Equity 6,31 M 5,03 M 6,18 M 10,34 M 9,06 M
Total Debt — — — — —
Cash & Equivalents 4,75 M 3,91 M 3,52 M 11,37 M 9,84 M
Current Assets 7,39 M 7,11 M 7,68 M 11,57 M 10,40 M
Current Liabilities 650 183,0 1,66 M 775 590,0 436 318,0 490 039,0